Skip to main content
. 2019 Apr 12;32(7):649–656. doi: 10.1093/ajh/hpz055

Table 1.

Baseline characteristics of study participants by tertile of serum sodium level

Variable Tertile 1 (≤138 mmol/L) (n = 1,777) Tertile 2 (139–140 mmol/L) (n = 2,927) Tertile 3 (≥141 mmol/L) (n = 4,109) P value
Age, years 68 ± 9 67 ± 10 68 ± 9 <0.0001
Sex, n (%) male 1208 (68) 1968 (67) 2527 (62) <0.0001
Race, n (%) white 1131 (64) 1686 (58) 2231 (54) <0.0001
Study randomization group, n (%) intensive treatment group 887 (50) 1460 (50) 2072 (50) 0.88
Prevalent CVD, n (%) 346 (20) 559 (19) 886 (22) 0.025
Prevalent heart failure, n (%) 55 (3) 87 (3) 176 (4) 0.006
Prevalent CKD, n (%) 468 (26) 814 (28) 1249 (30) 0.003
Smoking status, n (%) 0.003
Never smoked 722 (41) 1294 (44) 1855 (45)
Former smoker 776 (44) 1238 (42) 1744 (42)
Current smoker 279 (16) 395 (14) 510 (12)
MAP, mm Hg 98 ± 11 99 ± 11 99 ± 12 0.0025
Heart rate, bpm 69 ± 13 68 ± 12 68 ± 12 0.0002
Body mass index, kg/m2 29.2 ± 5.7 30.3 ± 5.9 29.9 ± 5.7 <0.0001
eGFR, ml/minute/1.73 m2 73.7 ± 21.8 72.5 ± 20.7 70.2 ± 20.1 <0.0001
Urinary albumin to creatinine ratio 9.9 (5.8, 24.3) 9.0 (5.4, 19.3) 9.8 (5.7, 22.6) 0.058
Antihypertensive agents, no./patient, n (%) 0.005
0 139 (8) 290 (10) 376 (9)
1 529 (30) 928 (32) 1317 (32)
2 656 (37) 993 (34) 1362 (33)
3 357 (20) 595 (20) 816 (20)
4 96 (5) 121 (4) 238 (6)
Diuretic use, n (%) 938 (53) 1361 (47) 1835 (45) <0.0001
Serum sodium, mmol/L 137 ± 2 140 ± 1 142 ± 1 <0.0001
Pulse pressure, mm Hg 61 ± 15 60 ± 14 63 ± 15 <0.0001

Data are mean ± SD, median (interquartile range), or n (%).Comparisons across tertiles were made using a Chi-square test for categorical data and analysis of variance for continuous variables. Abbreviations: CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate (Modification of Diet in Renal Disease equation); MAP, mean arterial pressure.